Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 56Recruiting 52Terminated 33Active not recruiting 24Unknown 9Withdrawn 8Not yet recruiting 3Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 84Thoracic 5Genitourinary 4Gastrointestinal 4Head & Neck 3Gynecologic 3Dermatologic 2Sarcoma 1Plasma cell 1Other solid neoplasm 1CNS 1

Conditions

Uterine Cervical Neoplasms 127Ovarian Neoplasms 105Endometrial Neoplasms 79Uterine Cervical Dysplasia 19Papillomavirus Infections 16Breast Neoplasms 16Fallopian Tube Neoplasms 15Carcinoma, Ovarian Epithelial 15Neoplasms 11Colorectal Neoplasms 11Vulvar Neoplasms 10Cervical Cancer Screening 10Carcinoma, Non-Small-Cell Lung 10Recurrence 9Neoplasm Metastasis 9Endometrial Hyperplasia 9Prostatic Neoplasms 8Acquired Immunodeficiency Syndrome 8Uterine Neoplasms 7Stomach Neoplasms 7Squamous Intraepithelial Lesions 6Locally Advanced Cervical Cancer 6Anus Neoplasms 6Vaginal Neoplasms 5Pancreatic Neoplasms 5Melanoma 5Lung Neoplasms 5Head and Neck Neoplasms 5Sarcoma 4Peritoneal Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Triple Negative Breast Neoplasms × Gynecologic × Clear all
NCT07527819 2026-04-14

FERTILE

Peter MacCallum Cancer Centre, Australia

Not yet recruiting
75 enrolled
BreastGynecologic

Inflammation, Primary Ovarian Insufficiency, Triple Negative Breast Neoplasms

NCT06976021 2025-05-16

INTROSPECTION

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Not yet recruiting
60 enrolled
BreastDermatologicGenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Melanoma, Triple Negative Breast Neoplasms

NCT06724263 2024-12-09

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Tasly Biopharmaceuticals Co., Ltd.

Phase 2 Not yet recruiting
120 enrolled
BreastGastrointestinalGynecologicThoracic

Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡